| Detected | Trial | Change |
|---|---|---|
| 2026-08-09 | NCT06511492 Longitudinal Surveillance of Rectal Colonization and Transmission by Resistant Bacteria… |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-09 | NCT06232265 An Observational Study on Predicting the Efficacy of Immunotherapy for NSCLC Based on… |
overall status: Recruiting → Unknown |
| 2026-08-09 | NCT05996484 Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for… |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-09 | NCT05877573 Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for… |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT06532214 Clinical Retrospective Study Analysis of Postoperative Complications Following Hepatectomy |
overall status: Recruiting → Unknown |
| 2026-07-29 | NCT07452055 Large Language Model-Based Emotional Management for Breast Cancer Patients |
overall status: Not Yet Recruiting → Active, Not Recruiting |
| 2026-07-29 | NCT07452055 Large Language Model-Based Emotional Management for Breast Cancer Patients |
date change Primary completion pushed: 2026-10-01 -> 2026-11-30 |
| 2026-07-29 | NCT07452055 Large Language Model-Based Emotional Management for Breast Cancer Patients |
date change Completion pushed: 2026-11-01 -> 2026-12-20 |
| 2026-07-24 | NCT07693881 Prevention of Epstein-Barr Virus Reactivation With the ATG-based Haploidentical Protocol… |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-13 | NCT07762573 Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment in COPD… | Recruiting | |
| 2026-08-13 | NCT07763184 mNGS for IFD in Patients With Hematological Malignancies | Not Yet Recruiting | |
| 2026-08-13 | NCT07764224 Cold Versus Hot Snare Endoscopic Mucosal Resection for Intermediate-Size Flat… | Not Yet Recruiting | |
| 2026-08-12 | NCT07759960 Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the… | Recruiting | |
| 2026-08-10 | NCT07754188 Early Complications After Flow Diverter Versus Stent-Assisted Coiling for Unruptured… | Recruiting | |
| 2026-08-05 | NCT07746960 Chemotherapy With the Ralox Regimen Combined With Anlotinib and Penpulimab for… | Early Phase 1 | Active, Not Recruiting |
| 2026-08-04 | NCT07744087 Modified Single-Incision Plus One-Port Versus Conventional Five-Port Laparoscopic… | Recruiting | |
| 2026-08-04 | NCT07745842 Impact of Linked Color Imaging on Sessile Serrated Lesion Miss Rate | Not Yet Recruiting | |
| 2026-08-03 | NCT07741591 Impact of Perioperative Antibiotic Use on Surgical Scarring | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06736860 | Tranexamic Acid in Patients With Traumatic Bleeding Based on Dynamic Monitoring of… | Trauma Coagulopathy | Recruiting |
| NCT06707194 | Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis | Spondyloarthritis (SpA) | Recruiting |
| NCT05728775 | REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac… | Anesthesia | Recruiting |
| NCT06763666 | CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML | Relapsed/Refractory AML | Not Yet Recruiting |
| NCT07231276 | Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric… | HBV | Not Yet Recruiting |
| NCT07528456 | Butylphthalide for Brain Edema After Endovascular Treatment | Acute Ischemic Stroke | Not Yet Recruiting |
| NCT07091994 | A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy | Ischemic Stroke, Acute | Not Yet Recruiting |
| NCT07604311 | Efficacy and Safety of Nefecon on Prevention of Relapse of IgA Nephropathy: a Randomized… | IgA Nephropathy (IgAN) | Not Yet Recruiting |
| Phase 3 | |||
| NCT03919552 | Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced… | Cisplatin | Recruiting |
| NCT06810791 | HVA vs IA/DA or VA in the Treatment of ND HR-AML | Newly Diagnosed Acute Myeloid Leukemia With High Risk | Recruiting |
| NCT07203352 | Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL | Acute Lymphoblastic Leukemia | Recruiting |
| Phase 2/3 | |||
| NCT07052422 | VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies… | Older Patients | Not Yet Recruiting |
| NCT07174375 | PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy | Acute Ischemic Stroke | Not Yet Recruiting |
| NCT07264010 | Sorafenib Combined With Venetoclax as Pre-emptive Therapy Strategy for MRD+ AML: a… | Acute Myeloid Leukaemia (AML) | Not Yet Recruiting |
| NCT07539779 | Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With… | Luspatercept | Not Yet Recruiting |
| NCT07603349 | Adaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or… | Gastric Adenocarcinoma | Not Yet Recruiting |
| NCT07636486 | Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological… | Luspatercept | Not Yet Recruiting |
| Phase 2 | |||
| NCT05825443 | Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients | Immunotherapy | Recruiting |
| NCT06177925 | A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent… | Respiratory Tract Neoplasms | Recruiting |
| NCT06220487 | A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and… | Acute Lymphoblastic Leukemia | Recruiting |
| NCT06298968 | Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab… | Intrahepatic Cholangiocarcinoma | Recruiting |
| NCT05214222 | Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal… | Advanced Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT06843889 | A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in… | Locally Advanced Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT06429696 | PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for… | Small Cell Lung Cancer Extensive Stage | Recruiting |
| NCT06157996 | Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With… | Gastric Cancer | Recruiting |